Do Portacaths or Hickman lines have a higher risk of catheter-related bloodstream infections in children with leukaemia?

Archives of Disease in Childhood

Volumn 95, Issue 3, 2010, Pages 239-241

  Alexander, Natasha ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; BLOOD CULTURE; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; FEBRILE NEUTROPENIA; FEMALE; HUMAN; NOTE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; CENTRAL VENOUS CATHETERIZATION; EVIDENCE BASED MEDICINE; INDWELLING CATHETER; INSTRUMENTATION; METHODOLOGY; REVIEW;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK ASSESSMENT;

EID: 77949904898     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.176545     Document Type: Note

References (23)

1. Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol 2007;29:261-78.
2. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007;65(Suppl 1):S1-64.
3. British Committee for Standards in Haematology. BCSH guidelines on the insertion and management of central venous lines. Br J Haematol 1997;98:1041-7.
4. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 2002;110:e51.
5. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-71.
6. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53-8.
7. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358-65.
8. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168-74.
9. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130-6.
10. La Quaglia MP, Lucas A, Thaler HT, et al. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 1992;27:840-2.
11. Mirro J Jr, Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 1990;25:120-4.
12. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-8.
13. Penel N, Neu JC, Clisant S, et al. Risk factors for early catheter-related infections in cancer patients. Cancer 2007;110:1586-92.
14. Ross MN, Haase GM, Poole MA, et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988;167:141-4.
15. Tweddle DA, Windebank KP, Barrett AM, et al. Central venous catheter use in UKCCSG oncology centres. United Kingdom Children's Cancer Study Group and the Paediatric Oncology Nursing Forum. Arch Dis Child 1997;77:58-9.
16. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988;142:536-40.
17. Abbas AA, Fryer CJ, Paltiel C, et al. Factors infl uencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004;42:325-31.
18. Adler A, Yaniv I, Solter E, et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006;28:23-8.
19. Alfredsdóttir IH, Thors VS, Gudnason T, et al. [Bacteremia in children with tumors or malignant diseases 1991-2000]. Laeknabladid 2008;94:531-9.
20. Flynn PM, Willis B, Gaur AH, et al. Catheter design infl uences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003;21:3520-5.
21. Hengartner H, Berger C, Nadal D, et al. Port-A-Cath infections in children with cancer. Eur J Cancer 2004;40:2452-8.
22. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement. J Clin Oncol 2005;23:3024-9.
23. Sotir MJ, Lewis C, Bisher EW, et al. Epidemiology of device-associated infections related to a longterm implantable vascular access device. Infect Control Hosp Epidemiol 1999;20:187-91.